These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29950269)

  • 1. Aspirin in Primary Prevention of Myocardial Infarction/Angina and Stroke in Hypertensive Patients.
    Almas A; Ghazni MS; Hashmani S; Mushtaq Z
    J Coll Physicians Surg Pak; 2018 Jul; 28(7):574. PubMed ID: 29950269
    [No Abstract]   [Full Text] [Related]  

  • 2. Aspirin for Primary Prevention.
    Richman IB; Owens DK
    Med Clin North Am; 2017 Jul; 101(4):713-724. PubMed ID: 28577622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin for the prevention of cardiovascular disease: recommendation statement.
    Am Fam Physician; 2011 Jun; 83(12):1464-8. PubMed ID: 21671547
    [No Abstract]   [Full Text] [Related]  

  • 4. Aspirin for the prevention of cardiovascular disease.
    Lin KW
    Am Fam Physician; 2011 Jun; 83(12):1469-70. PubMed ID: 21671548
    [No Abstract]   [Full Text] [Related]  

  • 5. Low-dose aspirin therapy for chronic stable angina. A randomized, placebo-controlled clinical trial.
    Ridker PM; Manson JE; Gaziano JM; Buring JE; Hennekens CH
    Ann Intern Med; 1991 May; 114(10):835-9. PubMed ID: 2014943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of aspirin on mortality in the primary prevention of cardiovascular disease.
    Raju N; Sobieraj-Teague M; Hirsh J; O'Donnell M; Eikelboom J
    Am J Med; 2011 Jul; 124(7):621-9. PubMed ID: 21592450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial.
    Ikeda Y; Shimada K; Teramoto T; Uchiyama S; Yamazaki T; Oikawa S; Sugawara M; Ando K; Murata M; Yokoyama K; Ishizuka N
    JAMA; 2014 Dec; 312(23):2510-20. PubMed ID: 25401325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A long-term risk-benefit analysis of low-dose aspirin in primary prevention.
    Wu IC; Hsieh HM; Yu FJ; Wu MC; Wu TS; Wu MT
    Eur J Clin Invest; 2016 Feb; 46(2):130-40. PubMed ID: 26640116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.
    Ridker PM; Cook NR; Lee IM; Gordon D; Gaziano JM; Manson JE; Hennekens CH; Buring JE
    N Engl J Med; 2005 Mar; 352(13):1293-304. PubMed ID: 15753114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of aspirin and statins for the primary prevention of myocardial infarction and stroke in patients with human immunodeficiency virus infection.
    Park TE; Yusuff J; Sharma R
    Int J STD AIDS; 2016 May; 27(6):447-52. PubMed ID: 25957325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is ticlopidine more effective than aspirin in preventing adverse cardiovascular events after myocardial infarction (MI)?
    Olson J; Huntington J
    J Fam Pract; 2001 Jul; 50(7):623. PubMed ID: 11485713
    [No Abstract]   [Full Text] [Related]  

  • 12. Aspirin use for primary prevention in elderly patients.
    Terrosu P
    Monaldi Arch Chest Dis; 2016 Jun; 84(1-2):728. PubMed ID: 27374042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose aspirin for primary prevention of cardiovascular events in patients with diabetes: a meta-analysis.
    Stavrakis S; Stoner JA; Azar M; Wayangankar S; Thadani U
    Am J Med Sci; 2011 Jan; 341(1):1-9. PubMed ID: 21191260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group.
    Juul-Möller S; Edvardsson N; Jahnmatz B; Rosén A; Sørensen S; Omblus R
    Lancet; 1992 Dec; 340(8833):1421-5. PubMed ID: 1360557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin for Primary Prevention of Cardiovascular Diseases: Current Concepts, Unanswered Questions and Future Directions.
    Castro-Torres Y; Katholi RE; Yar Khan N
    Hellenic J Cardiol; 2015; 56(6):461-74. PubMed ID: 26685291
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical Inquiries: What are the benefits and risks of daily low-dose aspirin for primary prevention of CV events?
    Mutter J; Grandy R; Hulkower S; Stigleman S
    J Fam Pract; 2018 Apr; 67(4):247-248. PubMed ID: 29614147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin in the primary prevention of angina pectoris in a randomized trial of United States physicians.
    Manson JE; Grobbee DE; Stampfer MJ; Taylor JO; Goldhaber SZ; Gaziano JM; Ridker PM; Buring JE; Hennekens CH
    Am J Med; 1990 Dec; 89(6):772-6. PubMed ID: 2252045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A short-term risk-benefit analysis of occasional and regular use of low-dose aspirin in primary prevention of vascular diseases: a nationwide population-based study.
    Wu IC; Hsieh HM; Wu MT
    BMJ Open; 2015 Jan; 5(1):e006694. PubMed ID: 25575876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin for primary prevention of cardiovascular disease in diabetes mellitus.
    Pignone M; Williams CD
    Nat Rev Endocrinol; 2010 Nov; 6(11):619-28. PubMed ID: 20856266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac safety in the European Stroke Prevention Study 2 (ESPS2).
    Diener HC; Darius H; Bertrand-Hardy JM; Humphreys M;
    Int J Clin Pract; 2001 Apr; 55(3):162-3. PubMed ID: 11351768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.